S32 heads into its July 20 production report carrying its worst monthly loss in recent memory, with the stock down 19% over the past month to AUD 3.90, while most of its peer group has also been under heavy selling pressure.
The price decline is the dominant story here, and the lending market confirms it has been driven by genuine holders selling rather than short sellers pressing the stock. Short interest is low — just 1.2% of the free float — and has actually fallen 11% over the past month. Borrow availability is exceptionally loose, running at 2,828%, meaning there are roughly 28 shares still available to borrow for every one already lent out. That is the highest availability reading of the past year, well above the 52-week low of 1,932%. Cost to borrow is a modest 1.82% and has eased 19% over the past week, even as it has climbed 44% from a month ago when it dipped below 1.15%. None of this points to a short-driven selloff — the borrow market is simply too relaxed for that thesis to hold. The ORTEX short score of 32.4 sits near a two-week low, reinforcing that view.
The Street is not offering much conviction either way. The consensus is a hold, split between three buys and five holds among the analysts covering the stock. The mean price target is AUD 3.35 — actually below the current price of AUD 3.90, which is unusual and worth flagging as a potential stale-data issue; it may reflect targets that have not been fully refreshed since the stock's recent drop. No recent analyst changes appear in the data. Valuation multiples have been compressing alongside the share price: the P/E has contracted by roughly 1.4 turns over the past 30 days to 11.6x, and EV/EBITDA has come in to 5.3x, down about 0.25x on the same horizon. The price-to-book is 1.27x, also moving lower. Factor scores offer a mixed read — earnings momentum over 30 days ranks in the 84th percentile, which is a meaningful positive, but forward earnings growth ranks in just the 25th percentile, reflecting the drag from weaker commodity prices. The dividend score ranks in the 83rd percentile, and the most recent declared dividend was AUD 0.055 per share.
The peer comparison sharpens the picture. BHP, the closest correlated name at 65%, fell less than 1% on the week — a meaningfully shallower move than S32's 5.8% drop. SFR also underperformed at -3.7%, but S32's decline was the steepest among the larger diversified names. GGP and WAF fared worse, dropping 13.9% and 15.2% respectively, though both are smaller and more commodity-specific. S32's underperformance relative to BHP stands out given their high correlation, suggesting stock-specific selling pressure beyond the broader metals and mining weakness.
Institutional ownership is large and concentrated in passive hands. State Street holds 8.2%, BlackRock 7.3%, and AustralianSuper 7.2% — together over 22% of the company. The latter's last reported change was a build of 47.6 million shares, though that filing dates to January 2026. Macquarie Investment Management trimmed 22 million shares as of February 2026, while its related entity added 20 million shares by May 2026 — a wash in aggregate. Insider data is stale, with no activity reported in the past 90 days and the most recent filing from February 2026.
S32's next scheduled production report on July 20 is the focus — after two consecutive earnings-day drops of around 5%, the setup heading into that release, with the stock already down nearly 19% this month, will determine whether patient holders see the current price as already pricing in the bad news.
See the live data behind this article on ORTEX.
Open S32 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
